Ann Kessler - Epigenomics AG Insider

Member of the Supervisory Board

Dr. Ann Clare Kessler, Ph.D. is Vice Chairwoman of the Supervisory Board of Epigenomics AG since May 2, 2012. She was Member of the Supervisory Board since June 28, 2005. For more than 30 years, she held several senior positions at HoffmannLa Roche Inc. in the United States, including Vice President and Head of Exploratory Research and Vice President of Pharmacology and Chemotherapy, prior to moving to Switzerland where she was in charge of the International Project Management group of HoffmannLa Roche in Basel for another five years until 1995. She serves on the Board of Directors of MedGenesis Therapeutix, Inc., among others. She holds a BS degree in Biology, which she gained from College of Notre Dame in 1965 a MS degree in Biochemistry, which she obtained from North West London University in 1967 as well as a Doctorate in Philosophy degree in Biochemistry, which she earned from New York University in 1973.
  Executive Since 2012      
49 30 243 450

Management Efficiency

The company has return on total asset (ROA) of (25.16) % which means that it has lost $25.16 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (70.57) % meaning that it generated substantial loss on money invested by shareholders.

Similar Executives

Showing few of many executives


Jocelyn VillarAltamiraManila Electric Co
Lemuel QuilosAboitiz Power Corp
Jasmine OportoAboitiz Power Corp
Boon LooGreat Eastern Holdings Limited
Jun ChoiSK Innovation
M OportoAboitiz Power Corp
Joerg PfirrmannSartorius Stedim Biotech SA
Dominique BalySartorius Stedim Biotech SA
Teresita SyCosonBDO Unibank Inc
Catherine AtayAboitiz Power Corp
Teresita SyBDO Unibank Inc
Jang SeoSK Innovation
Joseph GonzalesAboitiz Power Corp
Pakshong WongGreat Eastern Holdings Limited
Kok LeeGreat Eastern Holdings Limited
Ronnie TanGreat Eastern Holdings Limited
Susan ValdezAboitiz Power Corp
Pascualito MasionAboitiz Power Corp
Simeon FerrerManila Electric Co
Mun YoonGreat Eastern Holdings Limited
Sabino AcutBDO Unibank Inc

Entity Summary

Epigenomics AG, a molecular diagnostics company, engages in developing and commercializing a pipeline of proprietary solutions for screening and diagnosis of cancer in Europe, North America, and internationally. Epigenomics AG [EPGNF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Epigenomics AG to your portfolio
Top Management
Epigenomics AG Leadership Team
Albert Weber, President
Antje Zeise, Executive
Guenther Reiter, Executive
Gregory Hamilton, CEO, MBA
Ann Kessler, Executive
Heino Prondzynski, Chairman
Thomas Taapken, CFO
Annett Dietrich, Executive
Noel Doheny, CEO
Nicola HennebergBusse, President
Uwe Staub, President, Ph.D
Peter Vogt, Executive
Stock Performance
Epigenomics AG Performance Indicators